CoChat

Efficacy and safety of insulin degludec given as part of basal–bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26‐week randomized, open‐label, treat‐to‐target non‐inferiority trial

Open access
Davies, M. J., Gross, J. L., Ono, Y., Sasaki, T., Bantwal, G., Gall, M. A., Niemeyer, M., Seino, H., on behalf of the BEGIN BB T1 study group · 2014 · Diabetes, Obesity and Metabolism
Cited by 53

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Aims: The efficacy and safety of insulin degludec ( IDeg ) was compared with insulin detemir ( IDet ), both administered once daily ( OD ) as basal treatment in participants with type 1 diabetes mellitus ( T1DM ). The primary outcome was non‐inferiority of IDeg to IDet in glycated haemoglobin ( HbA1c ) reduction after 26 weeks. Methods: This multinational, 26‐week, controlled, open‐label, parallel‐group trial randomized adults with T1DM to IDeg or IDet as OD basal insulin treatment combined with mealtime bolus insulin aspart ( IAsp ). Participants with T1DM treated with any basal–bolus insulin regimen for ≥12 months prior to the trial, a mean HbA1c ≤ 10.0% (85.8 mmol/mol) and body mass index ( BMI ) ≤35.0 kg/m 2 at screening participated in the trial ( IDeg : N = 302; IDet : N = 153). Results: After 26 weeks, HbA1c decreased 0.73% (8.0 mmol/mol) ( IDeg ) and 0.65% (7.1 mmol/mol) ( IDet ) [estimated treatment difference ( ETD ) IDeg–IDet : −0.09% (−0.23; 0.05) 95% CI (−10.0 mmol/mol [−2.6; 0.6] 95% CI ); confirming non‐inferiority]. Mean fasting plasma glucose improved in both groups, and was lower with IDeg than IDet [ ETD IDeg–IDet : −1.66 mmol/l (−2.37; −0.95) 95% CI , p < 0.0001]. The rate of confirmed hypoglycaemia was similar with IDeg and IDet [45.83 vs. 45.69 episodes per patient‐year of exposure ( PYE ); estimated rate ratio ( RR ) IDeg / IDet : 0.98 (0.80; 1.20) 95% CI , p = 0.86]. The rate of nocturnal confirmed hypoglycaemia was lower with IDeg than IDet [4.14 vs. 5.93 episodes per PYE ; RR IDeg / IDet : 0.66 (0.49; 0.88) 95% CI , p = 0.0049]. Adverse event profiles were similar between groups. Conclusion: IDeg administered OD in basal–bolus therapy effectively improved long‐term glycaemic control in participants with T1DM with a lower risk of nocturnal confirmed hypoglycaemia than IDet .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12298

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 53

Metadata

Authors
Davies, M. J., Gross, J. L., Ono, Y., Sasaki, T., Bantwal, G., Gall, M. A., Niemeyer, M., Seino, H., & on behalf of the BEGIN BB T1 study group
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2014-05-08
Volume
16
Issue
10
Pages
922-930
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2092860355
Cited by
53
References
13
FWCI
5.51
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.